Biotech News Sangamo Therapeutics

Sangamo Therapeutics: $2.7 Billion Deal with Biogen for Neurodegenerative Disorders

Biotech News | 02.03.2020

Sangamo Therapeutics and Biogen announced a global licensing collaboration deal for the development...

Biotech News Sangamo Therapeutics

Sangamo Therapeutics Hires New Chief Medical Officer

Biotech News | 01.10.2019

Sangamo today announced Bettina Cockroft as a new chief medical offier for its gene editing...